New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.
Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...
Scientists have developed a new artificial intelligence–powered blood test that may be able to detect early signs of serious ...
DNA fragmentation is a crucial first step in Next Generation Sequencing (NGS) workflows—from Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) to ChIP-seq and Minimal Residual Disease ...
The new product reinforces Meridian’s leadership in enzyme stabilization and enables simplified and decentralized Next-Generation-Sequencing sample preparation. CINCINNATI--(BUSINESS WIRE)--The Life ...
Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer. Diagnostic value of septin-9 methylation assay in the diagnosis of early-stage colorectal cancer and ...
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...
Liver disease is a growing health problem around the world, yet many people who develop it do not know they are sick until the disease has already become serious. Conditions such as liver fibrosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results